Related Experiment Videos
Involving the general practitioner in screening for cervical cancer
M E Boon1, S Beck, A Wijsman-Grootendorst
1Leiden Cytology and Pathology Laboratory, Leiden, The Netherlands.
Summary
General practitioners improved cervical cancer screening uptake in Leiden. This shift led to higher detection rates for precancerous lesions and invasive cervical cancer, particularly in high-risk groups.
Area of Science:
- Public Health
- Gynecologic Oncology
- Epidemiology
Background:
- Cervical cancer screening programs are crucial for early detection and prevention.
- The Leiden region transitioned its screening program in 1989, changing smear-taking personnel from paramedical staff to general practitioners (GPs).
Purpose of the Study:
- To evaluate the impact of involving general practitioners in cervical cancer screening on screening uptake and detection rates.
- To compare the effectiveness of GP-led screening versus paramedical-led screening.
Main Methods:
- Comparative analysis of screening data from before and after the program shift in Leiden.
- Evaluation of cytological and histological detection rates for severe dysplasia, carcinoma in situ, and invasive cervical cancer.
- Stratification of results by age group to identify high-risk populations.
Main Results:
- The 3-yearly cytological detection rate for severe dysplasia or worse increased significantly from 1.00 to 3.40 per thousand.
- Histological detection rates for severe dysplasia rose from 0.60 to 2.09 per thousand, and for carcinoma in situ from 0.35 to 1.36 per thousand.
- All six invasive cervical carcinomata were detected within the GP-led screening program (0.31%), indicating improved detection in high-risk groups.
Conclusions:
- General practitioner involvement in cervical cancer screening enhances program uptake and diagnostic yield.
- GPs are more effective in engaging 'high-risk' populations for screening.
- The shift to GP-led screening resulted in a notable increase in the detection of precancerous lesions and invasive cervical cancer.